Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

CiGal-EI-TEP is an exploratory study that aim to assess the diagnostic performance of 68Ga Positron emission tomography (PET) / Computed Tomography (CT) for the diagnosis of prosthetic valve infective endocarditis in comparison with the final diagnosis established according to the ESC 2023 criteria, after 3 months of follow-up, by a panel of experts.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• adult patient (over 18 years old);

• patient with a prosthetic heart valve;

• patient suspected of infective endocarditis (on clinical and/or microbiological and/or imaging data);

• patient whose history is discussed in the multidisciplinary meeting dedicated to endocarditis;

• patient beneficiary of a social security scheme;

• free, informed and written consent signed by the participant and the investigator.

Locations
Other Locations
France
CHU de Bordeaux
RECRUITING
Bordeaux
Contact Information
Primary
Carine GREIB, MD
carine.greib@chu-bordeaux.fr
(0)5 57 65 64 83
Backup
Sandrine FOUCHET
sandrine.fouchet@chu-bordeaux.fr
Time Frame
Start Date: 2024-11-22
Estimated Completion Date: 2026-11
Participants
Target number of participants: 40
Treatments
Experimental: 68Ga-citrate PET/CT
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov